On February 08, 2022 Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, reported that management will report its fourth quarter and full year 2021 financial results after market close on February 24th, 2022 (Press release, Zymeworks, FEB 8, 2022, View Source [SID1234607846]). Following the announcement, management will host a conference call and webcast to discuss financial results and provide a corporate update on February 24th, 2022 at 4:30 p.m. ET.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Conference Call and Webcast Information:
Telephone: 800-319-4610 (U.S. or Canada) or +1-604-638-5340 (international)
The event will be webcast live with dial-in details and webcast replays available on Zymeworks’ website at View Source